Manufacturers Life Insurance Company, The Harrow Health, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Harrow Health, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 11,080 shares of HROW stock, worth $290,406. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,080
Previous 11,552
4.09%
Holding current value
$290,406
Previous $519,000
28.52%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding HROW
# of Institutions
185Shares Held
21MCall Options Held
679KPut Options Held
1.27M-
Opaleye Management Inc. Boston, MA3.99MShares$105 Million26.33% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$56.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$49.1 Million0.0% of portfolio
-
Private Capital Management, LLC Naples, FL1.69MShares$44.4 Million6.85% of portfolio
-
Braidwell LP Stamford, CT907KShares$23.8 Million1.7% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $710M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...